Regulatory Sports Medicine Regenity Biosciences Receives 510(k) Clearance for RejuvaKnee™, a Groundbreaking Regenerative Meniscus Implant Device to Redefine the Standard of Care byJosh SandbergOctober 9, 2024
Financial Advanced Orthopedic Technologies, Implants and Regenerative Products Market Report, with Profiles of B. Braun Melsungen AG, Zimmer Biomet, Medtronic, Nuvasive and Stryker byJosh SandbergDecember 22, 2023
Biologics Spine Top Stories Dr. Gail Naughton, world-renowned authority in the multibillion-dollar regenerative medicine market, joins HippoFi as the Head of Regenerative Therapeutics and Commercialization byJosh SandbergNovember 7, 2023
Biologics Extremities Financial Spine U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program byJosh SandbergMarch 1, 2023
Biologics Spine Top Stories HippoFi’s Regenerative Therapeutics Division Launches PURbridge™ for Spine Surgery byChris StewartNovember 23, 2022
Financial The Worldwide Orthopedic Regenerative Surgical Products Industry is Expected to Reach $5.6 Billion by 2030 byChris StewartApril 21, 2022
Biologics Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane – The Next Generation in Amniotic Tissue Products byChris StewartFebruary 24, 2020
Biologics Spine Graftless Bone Transplants Soon to Be Reality: ADAM Takes 3D Bones to Clinical Trials byChris StewartDecember 3, 2019
Biologics With increasing incidence of bone and joint diseases and injuries, Regenerative Medicine Market is predicted to reach US $6.5B by 2019 byJosh SandbergJanuary 16, 2017